Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cordis
MedTech
Cordis’ sirolimus drug-coated balloon earns FDA approval
The FDA gave the green light to a first and only sirolimus drug-eluting balloon designed by Cordis to treat coronary in-stent restenosis.
Joseph Keenan
Sep 22, 2026 8:17am
Cordis absorbs drug-eluting balloon maker MedAlliance for $235M
Oct 20, 2022 11:38am
InnovHeart nabs J&J, Haemonetics alum as CEO
Mar 30, 2022 11:28am
FDA stamps Class I label on Cordis angiographic catheter recall
Sep 24, 2021 12:16pm
Cardinal Health to sell its Cordis device division in $1B deal
Mar 15, 2021 9:30am
FDA panel backs Cordis’ Incraft stent graft for aortic aneurysms
Jun 13, 2018 11:00am
